The trusted source for
healthcare information and
• ALI Technologies (Vancouver, CAN) has acquired Olicon Imaging Systems (Aliso Viejo, CA) for a cash payment. Olicon is a radiology image management company that markets multi-modality image management film digitization and teleradiology systems directly to end-users, and through an alliance with Shared Medical Systems.
• Andrx (Fort Lauderdale, FL) has reached agreement with Geneva Pharmaceuticals (Denver) for sales and marketing of some products. The agreement includes development and funding of controlled-release dosage forms of existing products that Andrx is developing for submission as new drug applications.
• Eclipsys (Delray Beach, FL) has completed its acquisition of MSI Solutions (Atlanta), a web application integration company. Eclipsys has acquired all of MSI’s stock in exchange for 2.375 million shares of Eclipsys common stock. Eclipsys will use MSI’s products in Enterprise Application Integration to provide web-enabling and integration of new and heritage Eclipsys solutions as well as that of Eclipsys customers’ existing information systems.
• IMS Health (London) has reached an agreement with Federfarma, the Italian Association of Pharmacies, to track drugs dispensed by about 16,000 Italian pharmacies. IMS plans to launch its Xponent database service in Italy which will allow it to track drugs by therapy and brands to help companies better deploy sales, marketing, and information resources. IMS also announced that NV Organon (the Netherlands) has renewed its sales management contract for IMS Health’s line of sales management services in the U.S. The agreement provides for delivering sales support products to the pharmaceutical company. In addition, IMS Health has signed an agreement with Brio Technology (Palo Alto, CA) to develop next-generation sales optimization tools for the global pharmaceutical industry. The agreement will deliver a suite of end-to-end business products that increase targeting accuracy, sales effectiveness, and business productivity.
• Incyte Pharmaceuticals (Palo Alto, CA) and NV Organon have expanded their genomic partnership. Organon will receive access to the LifeSeq Gold assembled database, the ZooSeq animal model database, and data from Incyte’s GEM microarray technology in exchange for annual access and per array fees. Incyte also could receive future milestone payments and royalties on sales of products developed with Incyte technology and database information.
• Medsite.com (New York) said that it will acquire CreativeAspect for an undisclosed sum. As part of the acquisition, CreativeAspect co-founder Brian Shin will join Medsite.com as general manager of technology. CreativeAspect provides web-based calendar, e-mail, and collaboration software, and has a membership of more than 25,000 registered users.
• Netpulse Communications (San Francisco) has completed a marketing partnership and sponsorship agreement with HealthCentral.com (Berkeley, CA). Under the agreement, HealthCentral.com, a provider of health news and content, will integrate its brand, content and services in Netpulse’s Health Channel.
• Pointshare (Bellevue, WA), an online service provider for healthcare concerns in the Northwest, has partnered with U.S. West (Denver) to provide access to its online services via a direct subscriber line. Execu tives from both companies described this as the first secure DLS-based healthcare network in the U.S. DSL uses existing telephone lines to bring digital connections to homes and offices. A DSL line can carry both voice and data signals, meaning customers can use one phone line for both conventional telephone service and high-speed access to the web. Pointshare also has reached agreement with MD Consult (St. Louis) to distribute MD Consult’s online medical content site to physicians and hospitals.